Alzheimer's disease is a multifactorial disease that is characterized mainly by
Amyloid-β (A-β) deposits,
cholinergic deficit and extensive
metal (
copper,
iron)-induced oxidative stress. In this work we present details of the synthesis,
antioxidant and
copper-chelating properties,
DNA protection study,
cholinergic activity and
amyloid-antiaggregation properties of new multifunctional tacrine-7-hydroxycoumarin hybrids. The mode of interaction between
copper(II) and hybrids and interestingly, the reduction of Cu(II) to Cu(I) species (for complexes Cu-5e-g) were confirmed by EPR measurements. EPR spin trapping on the model Fenton reaction, using 5,5-dimethyl-1-pyrroline N-
oxide (DMPO) as a spin trap, demonstrated a significantly suppressed formation of
hydroxyl radicals for the Cu-5e complex in comparison with free
copper(II). This suggests that compound 5e upon coordination to free
copper ion prevents the Cu(II)-catalyzed decomposition of
hydrogen peroxide, which in turn may alleviate oxidative stress-induced damage. Protective activity of hybrids 5c and 5e against DNA damage in a Fenton system (
copper catalyzed) was found to be in excellent agreement with the EPR spin trapping study. Compound 5g was the most effective in the inhibition of
acetylcholinesterase (hAChE, IC50=38nM) and compound 5b was the most potent inhibitor of
butyrylcholinesterase (hBuChE, IC50=63nM). Compound 5c was the strongest inhibitor of A-β1-40 aggregation, although a significant inhibition (>50%) was detected for compounds 5b, 5d, 5e and 5g. Collectively, these results suggest that the design and investigation of multifunctional agents containing along with the
acetylcholinesterase inhibitory segment also an
antioxidant moiety capable of alleviating
metal (
copper)-induced oxidative stress, may be of importance in the treatment of
Alzheimer's disease.